Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NorthView Acquisition Corp | Chief Executive Officer, Director, 10%+ Owner | Private Warrants to purchase common stock | 5.16M | Dec 20, 2021 | By NorthView Sponsor I, LLC | ||
NorthView Acquisition Corp | Chief Executive Officer, Director, 10%+ Owner | Common Stock | 4.74M | Dec 20, 2021 | By NorthView Sponsor I, LLC | ||
Onconova Therapeutics, Inc. | Director | Stock Option (right to purchase) | 66.5K | Aug 10, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ONTX | Onconova Therapeutics, Inc. | Aug 10, 2023 | 1 | $0 | 4 | Aug 14, 2023 | Director |
ONTX | Onconova Therapeutics, Inc. | Aug 18, 2022 | 1 | $0 | 4 | Aug 19, 2022 | Director |
PMCB | PharmaCyte Biotech, Inc. | Aug 15, 2022 | 0 | $0 | 3 | Aug 23, 2022 | Director |
NVAC | NorthView Acquisition Corp | Dec 20, 2021 | 1 | $5.16M | 4 | Dec 23, 2021 | Chief Executive Officer, Director, 10%+ Owner |
NVAC | NorthView Acquisition Corp | Dec 20, 2021 | 0 | $0 | 3 | Dec 23, 2021 | Chief Executive Officer, Director, 10%+ Owner |
ONTX | Onconova Therapeutics, Inc. | Jul 30, 2021 | 1 | $0 | 4 | Jul 30, 2021 | Director |